Diana Hausman, Chief Medical Officer at Zymeworks Inc. (ZYME), sold 40,000 shares at $45.00 ($1.8M) on 2020-09-14, disclosed to the SEC on 2020-09-16.
Open-market sale of $1.8M ZYME by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ZYME | SELL | 2021-03-12 | $37K | — | Filing → |
| ZYME | SELL | 2020-12-04 | $665K | — | Filing → |
| ZYME | SELL | 2020-12-03 | $2.1M | — | Filing → |